David R. Bauer
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/25898_drbauer.jpg?itok=Y1b0J_im)
Filters
Adagene $161 million IPO
We advised Adagene on its IPO and Nasdaq listing
Bolt Biotherapeutics $230 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Immunocore $297 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Terns Pharmaceuticals $127.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Revolution Medicines $300 million follow-on offering
We advised the underwriters in connection with the equity offering
CureVac $450 million public offering
We advised CureVac on the equity offering
Surgalign Holdings $37.5 million follow-on offering
We advised the underwriters on the equity offering
Personalis, Inc. $150 million stock offering
We advised the underwriters on the equity offering
Precigen $129 million common stock offering
We advised the underwriters in connection with the SEC-registered equity offering
CytomX Therapeutics $100 million follow-on offering
We advised the joint book-running managers in connection with the equity offering